PMVP Reports $112.9M Cash Runway, Orphan Drug Designation, 34% ORR in Ovarian Cancer, NDA Planned Q1 2027
PMV Pharmaceuticals, Inc · PHARMACEUTICAL PREPARATIONS · Now $1.23
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS